Artificial Intelligence Blogs

09|02|26

Beyond AI-Enabled: Why a New Partner Model Is Vital for Pharmaceutical Marketing in Europe

European pharmaceutical marketers are navigating a uniquely complex landscape, balancing diverse healthcare systems, regulatory environments and market-specific needs. As AI continues to transform commercialization, the conversation must move beyond efficiency gains and automation toward a more fundamental question: what should the future client-agency partnership look like? In this POV, Michael Le Brocq, Global Head of […]

08|06|26

What ChatGPT Ads Mean for Pharma Search

Explore the critical differences between ChatGPT Ads and standard search, the unique regulatory challenges ahead, and the exact steps pharma brands must take now to prepare for inevitable platform access.

07|06|26

Beyond the AI Hype: Why Authentic Connection Dominated Cannes 2026

At Cannes Lions 2026, the conversation wasn't about replacing humans with AI—it was about amplifying what makes us human. Susan Perlbachs, Chief Creative Officer, explores the rise of Human Maxing and the lessons shaping the future of creativity.

06|23|26

Navigating the New Era of Pharma Search with Google AI Overviews 

As Google AI Overviews increasingly become the front door for pharmaceutical discovery, life science brands must adapt their strategies to maintain visibility in a changing search landscape.  Josie Black, Head of SEO and GEO, explored this rapid shift to AI-powered, synthesized answers in discussion with pharmaphorum.

06|11|26

Beyond the Molecule: The New Reality of Oncology Commercialization 

As ASCO 2026 made clear, oncology has entered a “post-molecule” era, where clinical efficacy is no longer the primary differentiator, but a baseline expectation. In a new article for PharmaLive, Tim Lewis explores how success now depends on how well therapies integrate into an increasingly complex, overburdened care ecosystem.

05|21|26

Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care? 

In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.

05|20|26

Google AI Mode & What It Means for Pharma Search

Google’s shift to AI‑generated search is redefining how patients and healthcare professionals discover information. As advertising moves into conversational, intent‑driven experiences, pharma marketers are being pushed to rethink how they show up in moments that increasingly shape decision‑making.

05|15|26

2026 Pharma AI Overviews Report

In the past four years, AI has altered how users and technology discover and engage with information and continues to evolve and reshape the digital landscape. To better understand this transformation, our GEO/SEO team analyzed 10,000 pharmaceutical-specific keywords, uncovering a hidden layer of AI background searches and a rapidly changing landscape where nearly 75% of keywords now trigger AI Overviews and sources shift frequently.

05|11|26

What Adobe Summit 2026 Signals for Pharma Marketing 

Adobe Summit 2026 highlighted a major shift in AI, uncovering new implications for how marketing gets done in pharma.  Our latest POV from our team that attended this year’s summit explores what this shift means and how pharma marketers can start preparing for what’s next. Readers will gain insight into:  Download the POV to learn more.

04|29|26

4 Takeaways from Google Cloud’s NEXT 2026 and What’s on the Horizon for Pharma

What does the next chapter of AI‑driven transformation mean for pharma? Faruk Capan, Chief Innovation Officer, recently penned an article for pharmaphorum distilling four key takeaways from Google Cloud’s NEXT 2026 conference, highlighting how the industry is moving beyond experimentation toward accountability, integration, and trust at scale. From connected systems to stronger AI governance, the piece offers timely perspective on what pharma organizations must do next to stay competitive.